TuHURA Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	3.62	12.66	3.67	14.25
Cash & Short-Term Investments	3.62	12.66	3.67	14.25
Cash Growth	-71.40%	245.35%	-74.28%	-
Other Receivables	0.67	0.64	0.33	-
Receivables	0.67	0.64	0.33	0.1
Other Current Assets	0.33	6.31	0.16	0.39
Total Current Assets	4.62	19.61	4.16	14.74
Property, Plant & Equipment	0.69	0.32	0.2	0.42
Goodwill	10.74	-	-	-
Long-Term Deferred Charges	11.28	-	-	-
Other Long-Term Assets	0.03	0.03	-	0.03
Total Assets	27.35	19.97	4.36	15.2
Accounts Payable	3.77	3.15	1.87	1.92
Accrued Expenses	1.75	2.02	1.57	0.84
Short-Term Debt	0.2	-	-	-
Current Portion of Leases	0.2	0.16	0.02	0.12
Other Current Liabilities	-	-	0.14	-
Total Current Liabilities	5.92	5.33	3.6	2.87
Long-Term Debt	-	-	2.32	-
Long-Term Leases	0.3	0.04	-	0.02
Long-Term Deferred Tax Liabilities	0.2	-	-	-
Total Liabilities	6.42	5.37	5.92	2.89
Common Stock	0.06	0.04	0.01	0
Additional Paid-In Capital	161.78	125.4	86.89	71.45
Retained Earnings	-141.18	-111.12	-88.47	-59.16
Total Common Equity	20.65	14.32	-1.58	12.3
Shareholders' Equity	20.93	14.59	-1.56	12.3
Total Liabilities & Equity	27.35	19.97	4.36	15.2
Total Debt	0.7	0.2	2.34	0.14
Net Cash (Debt)	2.92	12.45	1.32	14.11
Net Cash Growth	-76.56%	843.49%	-90.65%	-
Net Cash Per Share	0.06	0.67	0.11	-
Filing Date Shares Outstanding	63.58	43.68	68.01	-
Total Common Shares Outstanding	59.34	42.32	68.01	-
Working Capital	-1.3	14.28	0.56	11.87
Book Value Per Share	0.35	0.34	-0.02	-
Tangible Book Value	9.92	14.32	-1.58	12.3
Tangible Book Value Per Share	0.17	0.34	-0.02	-
Machinery	1.84	1.59	1.54	1.5
Leasehold Improvements	0.54	0.54	0.54	0.54

Source: S&P Capital IQ. Standard template. Financial Sources.